Bg pattern

BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

BUDESONIDA ALCON 50 micrograms/dose nasal spray suspension

Budesonide

Read this package leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this package leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

Contents of the package leaflet:

  1. What is BUDESONIDA ALCON 50 micrograms/dose and what is it used for
  2. What you need to know before you start using BUDESONIDA ALCON 50 micrograms/dose
  3. How to use BUDESONIDA ALCON 50 micrograms/dose
  4. Possible side effects
  5. Storage of BUDESONIDA ALCON 50 micrograms/dose
  6. Contents of the pack and further information

1. What is BUDESONIDA ALCON 50 micrograms/dose and what is it used for

This medicine contains budesonide, which has anti-inflammatory and antiallergic properties when applied to the nasal mucosa.

It is indicated for the relief of congestion, irritation, and localized discomfort in the nasal mucosa (rhinitis) that are a consequence of seasonal and chronic allergic processes. It is also used in vasomotor rhinitis and in the treatment of nasal polyps and their prevention after polypectomy.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you start using BUDESONIDA ALCON 50 micrograms/dose

Do not use BUDESONIDA ALCON 50 micrograms/dose

If you are allergic (hypersensitive) to budesonide or any of the other ingredients of BUDESONIDA ALCON 50 micrograms/dose (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to use BUDESONIDA ALCON 50 micrograms/dose.

  • Patient with pulmonary tuberculosis or with fungal or viral infections of the respiratory tract, or those patients previously treated with corticosteroids by systemic route (oral or injectable), should be treated with special caution and under medical supervision.
  • In long-term treatments, a review of the nasal mucosa should be performed at least once a year.
  • The use of the spray by more than one person can lead to contagion.
  • During treatment with this preparation, it should be taken into account that there is a potential risk of masking a local infection.
  • After the treatment period, it is recommended to discard the remaining preparation, even if it has not been fully consumed.
  • Contact your doctor if you experience blurred vision or other visual disturbances.

Children

Children should use BUDESONIDA ALCON 50 micrograms/dose only under the supervision of an adult to ensure correct administration and that the dose corresponds to that prescribed by the doctor.

Using BUDESONIDA ALCON 50 micrograms/dose with other medicines

No interactions have been described, although it is recommended to inform your doctor or pharmacist if you are using, or have recently used, any other medicine, including those obtained without a prescription.

On occasion, the simultaneous administration of an antihistamine eye drop may be useful to counteract the ocular effects produced by the allergy.

Pregnancy and breastfeeding

It will only be used during pregnancy and breastfeeding when the doctor considers it necessary.

Consult your doctor or pharmacist before using any medicine.

Driving and using machines

No effects on the ability to drive and use machines have been described.

This medicine contains potassium sorbate

This medicine may produce local skin reactions (such as contact dermatitis) because it contains potassium sorbate as an excipient.

Athletes are informed that this medicine contains budesonide, which may result in a positive test result in doping controls.

3. How to use BUDESONIDA ALCON 50 micrograms/dose

Follow the instructions for administration of BUDESONIDA ALCON 50 micrograms/dose indicated by your doctor. In case of doubt, consult your doctor or pharmacist.

The dosage should be individualized and may be modified according to medical criteria.

In adults and children from 6 years old, the usual recommended dose is two applications (100 mcg) in each nostril, in the morning and at night (total 400 mcg).

When symptoms start to improve, the dose can be reduced to one application (50 mcg) in each nostril, in the morning and at night (total 200 mcg).

Several days are required for the symptoms to disappear completely, using the recommended doses and intervals.

Treatment of seasonal rhinitis should be started, whenever possible, before exposure to the allergen.

In the treatment of nasal polyps, the daily dose can be increased up to 800 mcg.

Instructions for correct administration of the preparation:

Hand holding an inhalation device with mouthpiece and cap, showing steps one and two of useBefore the first application:

  • Remove the protective cap.
  • Shake the bottle-applicator assembly.
  • Actuate the pump the necessary number of times to

fill the valve mechanism and produce a correct spray.

Hand holding an auto-injector with the thumb pressing the activation button for injection

Mode of use. For each application:

  • Clean the nostrils with a tissue.
  • Remove the protective cap.
  • Shake the bottle-applicator assembly.
  • Tilt your head slightly forward and insert

the diffuser into one nostril, covering the other with your finger.

Repeat the same process in the other nostril.

After use, replace the protective cap.

The use of the spray by more than one person can lead to contagion.

If you use more BUDESONIDA ALCON 50 micrograms/dose than you should

Although no toxic symptoms are expected in case of overdose or accidental ingestion, in such cases, consult the Toxicology Information Service. Telephone 91 562 04 20.

If in any special circumstance you observe symptoms of edema, swelling of the face or moon face, etc., you should inform your doctor so that the appropriate measures can be taken.

If you forget to use BUDESONIDA ALCON 50 micrograms/dose

Do not use a double dose to make up for forgotten doses.

If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, BUDESONIDA ALCON 50 micrograms/dose can cause side effects, although not everybody gets them.

Occasionally, sneezing fits may occur immediately after using the spray.

Rarely, a slight nasal hemorrhage, nasal dryness, and irritation of the throat or blurred vision may occur.

Exceptionally, cases of cutaneous allergic reactions associated with the use of the preparation have been described. Extremely rare cases of perforation of the nasal septum have been reported after the use of nasal corticosteroids.

If you think any of the side effects you are experiencing are serious, or if you notice any side effect not mentioned in this leaflet, consult your doctor or pharmacist.

5. Storage of BUDESONIDA ALCON 50 micrograms/dose

No special storage conditions are required.

Keep this medicine out of the sight and reach of children.

Do not use BUDESONIDA ALCON 50 micrograms/dose after the expiry date stated on the packaging. The expiry date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the SIGRE collection point at your pharmacy. If you have any doubts, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Further information

Composition of BUDESONIDA ALCON 50 micrograms/dose

  • Each 100 ml contains 0.1 g of budesonide (DCI).
  • Each dose provides 50 mcg of budesonide. A spray bottle contains 200 doses.
  • Excipients: glucose, potassium sorbate, disodium edetate, cellulose and sodium carboxymethylcellulose, polysorbate 80, and purified water.

Appearance of the product and contents of the pack

BUDESONIDA ALCON 50 micrograms/dose is a medicine in the form of a nasal spray suspension, presented in glass bottles with 10 ml (200 doses of 50 mcg/dose).

Marketing authorization holder and manufacturer

Marketing authorization holder

M4 PHARMA, S.L.

C/ Tánger, 86

08018 Barcelona (Spain)

Manufacturer

LABORATORIO REIG JOFRE, S.A.

Gran Capita, 10.

Sant Joan Despi, Barcelona - Spain

This leaflet was last revised in June 2017

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION

Discuss questions about BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€55
0.0 (0)
Doctor

Marta Reguero Capilla

Allergology 8 years exp.

Dr Marta Reguero Capilla is an allergist and immunologist who works with both adults and children. She specialises in the diagnosis, treatment, and ongoing management of allergic and immune-related conditions through online consultations.

In her practice, Dr Reguero Capilla helps patients understand the causes of their symptoms, review test results, and choose appropriate treatment or monitoring strategies. Her consultations are suitable both for first-time assessments and for follow-up care over time.

Patients commonly consult Dr Marta Reguero Capilla for:

  • allergic rhinitis, seasonal allergies, and perennial allergy symptoms;
  • allergic conditions in adults and children;
  • bronchial asthma and allergy-related respiratory symptoms;
  • urticaria (acute and chronic) and angioedema;
  • food allergies and reactions to foods, additives, or medications;
  • atopic dermatitis, allergic rashes, and persistent itching;
  • unexplained or recurrent allergic reactions;
  • interpretation of laboratory tests, allergy testing, and immunology results;
  • immune system concerns, frequent infections, and reduced immune response;
  • ongoing medical follow-up and treatment adjustment.
Dr Reguero Capilla works in a structured and attentive manner, explaining medical decisions clearly and helping patients make informed choices about their own health or their child’s care.

When clinically appropriate, she may provide recommendations for further tests or referrals that patients can use within Spanish medical networks, including Sanitas and DKV, in accordance with the terms and conditions of those services.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION?
BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION?
The active ingredient in BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION is budesonide. This information helps identify medicines with the same composition but different brand names.
How much does BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION cost in pharmacies?
The average pharmacy price for BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION is around 4.06 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION?
BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION is manufactured by M4 Pharma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to BUDESONIDE ALCON 50 micrograms/DOSE NASAL SPRAY SUSPENSION?
Other medicines with the same active substance (budesonide) include BUDENA 64 micrograms NASAL SPRAY SUSPENSION, BUDESONIDE ALCON 100 micrograms/DOSE NASAL SPRAY SUSPENSION, BUDESONIDE ALDO-UNION 64 micrograms NASAL SPRAY SUSPENSION EFG. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media